NRX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.81 USD | -8.17% |
|
+8.91% | -38.91% |
| May. 06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
| May. 06 | NRx Pharmaceuticals, Inc. Announces Final Clinical Trial Results | CI |
Chart calendar NRx Pharmaceuticals, Inc.
f23d7698a1859f42d.ULZTMut47nyOTp3-PC7TwuRDrvv8njzEX2fpRFlrQF0.GcwrXYwLuD_iDd_GdRia9IMtl7W_2w6-HSqFD20hKz4n4n5X20zDEvsLqQ~cb9638538e4c332610e62816764b85ce
Upcoming events on NRx Pharmaceuticals, Inc.
Past events on NRx Pharmaceuticals, Inc.
| 2024-04-01 08:30 am | Q4 2023 Earnings Call |
| 2024-04-01 08:28 am | Q4 2023 Earnings Release |
| 2024-03-25 09:40 am | Ketamine Conference |
| 2024-03-20 | Extraordinary Shareholders Meeting |
| 2024-02-26 02:30 pm | BIO CEO & Investor Conference |
| 2024-01-08 11:00 am | LifeSci Partners Corporate Access Event |
| 2024-01-06 | Sachs Neuroscience Innovation Forum |
| 2023-12-19 11:00 am | Annual General Meeting |
| 2023-12-04 04:30 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-13 06:39 pm | Q3 2023 Earnings Release |
| 2023-10-12 04:00 pm | Dawson James Small Cap Growth Conference |
| 2023-09-21 09:15 am | Sidoti Small Cap Conference |
| 2023-09-12 05:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-14 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-14 04:09 pm | Q2 2023 Earnings Release |
| 2023-06-26 09:00 am | H.C. Wainwright Neuropsychiatry Virtual Conference |
| 2023-06-05 08:30 am | Business Update Call |
| 2023-05-16 08:30 am | Q1 2023 Earnings Call |
| 2023-05-16 06:47 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -44,4 -43,8 -1.36% | -27,8 -29,6 5.8% | -29,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -21,3 |
|
Net income Million USD | Released Forecast Spread | -93,1 | 0,00 0,00 - | 0,00 0,00 - | -21,3 |
|
EPS USD | Released Forecast Spread | -74,4 | 0,00 0,00 - | 0,00 0,00 - | -2,18 |
| Announcement Date | 31/03/22 | 30/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -9,60 -6,90 -39.13% | -9,14 -9,60 4.78% | -9,95 -9,40 -5.85% | -9,44 -9,00 -4.83% | -8,19 -9,65 15.15% | -5,81 -9,00 35.47% | -4,41 -6,15 28.36% | -5,00 | -5,00 | -5,00 | -5,00 | -5,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,30 | -5,30 | -5,30 | -5,30 | -5,30 | |||||||
|
Net income Million USD | Released Forecast Spread | -5,30 | -5,30 | -5,30 | -5,30 | -5,30 | |||||||
|
EPS USD | Released Forecast Spread | -0,55 | -0,55 | -0,54 | -0,54 | -0,53 | |||||||
| Announcement Date | 15/08/22 | 14/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 29/03/24 | - | - | - | - | - |
More events
Past sector events for NRx Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BRPA Stock
- Calendar NRx Pharmaceuticals, Inc.